MA
STRM

MYDA Advisors’s Streamline Health Solutions STRM Stock Holding History

MYDA Advisors’s Portfolio STRM Stock Details STRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-9,667
Closed -$297K – 333
2021
Q1 		$297K Buy
+9,667
New +$277K 0.08% 224

Other funds holding STRM

TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HIM
Herald Investment Management London, United Kingdom $718M AUM 91.16% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MYDA Advisors's STRM Position: Q2 2021 in Review

MYDA Advisors sold out of Streamline Health Solutions (STRM) in Q2 2021, closing a stake of 9,667 shares — an estimated $297K sold.

MYDA Advisors first reported a position in STRM in Q1 2021 and held it in 1 quarter. The position peaked at $297K in Q1 2021. 38 funds tracked by Wall St. Rank hold STRM as of Q2 2021.

  • MYDA Advisors reported no remaining Streamline Health Solutions position as of Q2 2021 after selling out during the quarter.
  • MYDA Advisors sold 9,667 Streamline Health Solutions shares in Q2 2021, an estimated $297K.
  • MYDA Advisors first reported a position in Streamline Health Solutions in Q1 2021 and held it in 1 quarter.
  • MYDA Advisors's Streamline Health Solutions position peaked at $297K in Q1 2021.
  • 38 funds tracked by Wall St. Rank held Streamline Health Solutions as of Q2 2021.

Based on MYDA Advisors's 13F filing for Q2 2021, filed 13 Aug 2021.